Attività Prestazioni Didattica Corsi Eventi Bandi Contatti
Istituto > Pubblicazioni > Anno 2007
Pubblicazioni Istituto inserite in PubMed e nell'Osservatorio della Ricerca - Anno 2007

Zamagni E, Nanni C, Patriarca F, Englaro E, Castellucci P, Geatti O, Tosi P, Tacchetti P, Cangini D, Perrone G, Ceccolini M, Brioli A, Buttignol S, Fanin R, Salizzoni E, Baccarani M, Fanti S, Cavo M. A prospective comparison of 18F-fluorodeoxyglucose positron emission tomography-computed tomography, magnetic resonance imaging and whole-body planar radiographs in the assessment of bone disease in newly diagnosed multiple myeloma. Haematologica. 2007 Jan;92(1):50-5.

Rossi L, Manfredini R, Bertolini F, Ferrari D, Fogli M, Zini R, Salati S, Salvestrini V, Gulinelli S, Adinolfi E, Ferrari S, Di Virgilio F, Baccarani M, Lemoli RM. The extracellular nucleotide UTP is a potent inducer of hematopoietic stem cell migration. Blood. 2007 Jan 15;109(2):533-42.

Malagola M, Damiani D, Martinelli G, Michelutti A, Cesana B, de Vivo AD, Piccaluga PP, Ottaviani E, Candoni A, Geromin A, Tiribelli M, Fanin R, Testoni N, Lauria F, Bocchia M, Gobbi M, Pierri I, Zaccaria A, Zuffa E, Mazza P, Priccolo G, Gugliotta L, Bonini A Case-control study of multidrug resistance phenotype and response to induction treatment including or not fludarabine in newly diagnosed acute myeloid leukaemia patients. Br J Haematol. 2007 Jan;136(1):87-95.

Rosti G, Iacobucci I, Bassi S, Castagnetti F, Amabile M, Cilloni D, Poerio A, Soverini S, Palandri F, Rege Cambrin G, Iuliano F, Alimena G, Latagliata R, Testoni N, Pane F, Saglio G, Baccarani M, Martinelli G. Impact of age on the outcome of patients with chronic myeloid leukemia in late chronic phase: results of a phase II study of the GIMEMA CML Working Party. Haematologica. 2007 Jan;92(1):101-5.

Vose JM, Panwalkar A, Belanger R, Coiffier B, Baccarani M, Gregory SA, Facon T, Fanin R, Caballero D, Ben-Yehuda D, Giles F. A phase II multicenter study of troxacitabine in relapsed or refractory lymphoproliferative neoplasms or multiple myeloma. Leuk Lymphoma. 2007 Jan;48(1):39-45.

Rosti G, Martinelli G, Baccarani M. In reply to ‘Cardiotoxicity of the cancer therapeutic agent imatinib mesylate’. Nat Med. 2007 Jan;13(1):15; author reply 15-6.

Zinzani PL, Musuraca G, Alinari L, Fanti S, Tani M, Stefoni V, Marchi E, Fina M, Pellegrini C, Castellucci P, Farsad M, Baccarani M. Predictive role of positron emission tomography in the outcome of patients with follicular lymphoma. Clin Lymphoma Myeloma. 2007 Jan;7(4):291-5.

Potenza L, Luppi M, Riva G, OttavianiE, Zucchini P,Morselli M, Volzone F,Forghieri F, Martinelli G, Torelli G May the correlation betweenKit-D816 mutationand AML1-ETO level change the use of prognostic factors int(8;21) AML? Leuk Res, 2007 Feb;31(2):269-71.

Arpinati M, Chirumbolo G, Saunthararajah Y, Stanzani M, Bonifazi F, Bandini G, Baccarani M, Rondelli D. Higher numbers of blood CD14+ cells before starting conditioning regimen correlate with greater risk of acute graft-versus-host disease in allogeneic stem cell transplantation from related donors. Biol Blood Marrow Transplant. 2007 Feb;13(2):228-34.

Palandri F, Amabile M, Rosti G, Bandini G, Benedetti F, Usala E, Angelucci E, Tiribelli M, Fanin R, Martinelli G, Baccarani M. Imatinib therapy for chronic myeloid leukemia patients who relapse after allogeneic stem cell transplantation: a molecular analysis. Bone Marrow Transplant. 2007 Feb;39(3):189-91.

Curti A, Aluigi M, Pandolfi S, Ferri E, Isidori A, Salvestrini V, Durelli I, Horenstein AL, Fiore F, Massaia M, Piccioli M, Pileri SA, Zavatto E, D’Addio A, Baccarani M, Lemoli RM. Acute myeloid leukemia cells constitutively express the immunoregulatory enzyme indoleamine 2,3-dioxygenase. Leukemia. 2007 Feb;21(2):353-5.

Bianchini M, Martinelli G, Renzulli M, Gonzalez Cid M, Larripa I. cDNA microarray study to identify expression changes relevant for apoptosis in K562 cells co-treated with amifostine and imatinib. Cancer Chemother Pharmacol. 2007 Feb;59(3):349-60.

Calonghi N, Pagnotta E, Parolin C, Molinari C, Boga C, Dal Piaz F, Brusa GL, Santucci MA, Masotti L. Modulation of apoptotic signalling by 9-hydroxystearic acid in osteosarcoma cells. Biochim Biophys Acta. 2007 Feb;1771(2):139-46.

Alviano F, Fossati V, Marchionni C, Arpinati M, Bonsi L, Franchina M, Lanzoni G, Cantoni S, Cavallini C, Bianchi F, Tazzari PL, Pasquinelli G, Foroni L, Ventura C, Grossi A, Bagnara GP. Term Amniotic membrane is a high throughput source for multipotent Mesenchymal Stem Cells with the ability to differentiate into endothelial cells in vitro. BMC Dev Biol. 2007 Feb 21;7:11.

Bussolari R, Candini O, Colomer D,Corradini F,Guerzoni C, Mariani SA,Cattelani S, Silvestri C, Pecorari L,Iacobucci I,Soverini S, Fasano T,Martinelli G, Cervantes F, Calabretta B Coding sequence and intron-exonjunctions ofthe c-myb gene are intact in the chronic phase and blast crisisstages ofchronic myeloid leukemia patients Leuk Res.2007 Feb;31(2):163-7.

Pileri SA, Ascani S, Cox MC, Campidelli C, Bacci F, Piccioli M, Piccaluga PP, Agostinelli C, Asioli S, Novero D, Bisceglia M, Ponzoni M, Gentile A, Rinaldi P, Franco V, Vincelli D, Pileri A Jr, Gasbarra R, Falini B, Zinzani PL, Baccarani M. Myeloid sarcoma: clinico-pathologic, phenotypic and cytogenetic analysis of 92 adult patients. Leukemia. 2007 Feb;21(2):340-50.

Mazzucconi MG, Fazi P, Bernasconi S, De Rossi G, Leone G, Gugliotta L, Vianelli N, Avvisati G, Rodeghiero F, Amendola A, Baronci C, Carbone C, Quattrin S, Fioritoni G, D’Alfonso G, Mandelli F; Gruppo Italiano Malattie Ematologiche dell’Adulto (GIMEMA) Th Therapy with high-dose dexamethasone (HD-DXM) in previously untreated patients affected by idiopathic thrombocytopenic purpura: a GIMEMA experience. Blood. 2007 Feb 15;109(4):1401-7.

Laszlo D, Rabascio C, Andreola G, Pruneri G, Raia V, Calabrese L, Radice D, Saronni L, Martinelli G. Chlorambucil - rituximab as first line combination therapy in follicular non-Hodgkin’s lymphoma: a clinical and biological analysis. Leuk Lymphoma. 2007 Feb;48(2):437-8.

Sanz MA, Labopin M, Gorin NC, de la Rubia J, Arcese W, Meloni G, Bacigalupo A, Alessandrino P, Carreras E, Iriondo A, Novitzky N, Jacobs P, Bandini G, Lo-Coco F, Frassoni F, Rocha V; Acute Leukemia Working Party (ALWP) of European Cooperative Group for Bl Hematopoietic stem cell transplantation for adults with acute promyelocytic leukemia in the ATRA era: a survey of the European Cooperative Group for Blood and Marrow Transplantation. Bone Marrow Transplant. 2007 Apr;39(8):461-9.

Hochhaus A, Kantarjian HM, Baccarani M, Lipton JH, Apperley JF, Druker BJ, Facon T, Goldberg SL, Cervantes F, Niederwieser D, Silver RT, Stone RM, Hughes TP, Muller MC, Ezzeddine R, Countouriotis AM, Shah NP. Dasatinib induces notable hematologic and cytogenetic responses in chronic-phase chronic myeloid leukemia after failure of imatinib therapy. Blood. 2007 Mar 15;109(6):2303-9.

Gori E, Arpinati M, Bonifazi F, Errico A, Mega A, Alberani F, Sabbi V, Costazza G, Leanza S, Borrelli C, Berni M, Feraut C, Polato E, Altieri MC, Pirola E, Loddo MC, Banfi M, Barzetti L, Calza S, Brignoli C, Bandini G, De Vivo A, Bosi A, Baccarani M. Cryotherapy in the prevention of oral mucositis in patients receiving low-dose methotrexate following myeloablative allogeneic stem cell transplantation: a prospective randomized study of the Gruppo Italiano Trapianto di Midollo Osseo nurses group. Bone Marrow Transplant. 2007 Mar;39(6):347-52.

Iacobucci I, Galletti L, Amabile M, Soverini S, Baccarani M, Martinelli G. Monitoring BCR-ABL transcript levels by real-time quantitative polymerase chain reaction: a linear regression equation to convert from BCR-ABL/B2M ratio to estimated BCR-ABL/ABL ratio. Haematologica. 2007 Mar;92(3):429-30.

Soverini S, Colarossi S, Gnani A, Castagnetti F, Rosti G, Bosi C, Paolini S, Rondoni M, Piccaluga PP, Palandri F, Giannoulia P, Marzocchi G, Luatti S, Testoni N, Iacobucci I, Cilloni D, Saglio G, Baccarani M, Martinelli G. Resistance to dasatinib in Philadelphia-positive leukemia patients and the presence or the selection of mutations at residues 315 and 317 in the BCR-ABL kinase domain. Haematologica. 2007 Mar;92(3):401-4.

Piccaluga PP, Agostinelli C, Califano A, Rossi M, Basso K, Zupo S, Went P, Klein U, Zinzani PL, Baccarani M, Dalla Favera R, Pileri SA. Gene expression analysis of peripheral T cell lymphoma, unspecified, reveals distinct profiles and new potential therapeutic targets. J Clin Invest. 2007 Mar;117(3):823-34.

Tazzari PL, Cappellini A, Ricci F, Evangelisti C, Papa V, Grafone T, Martinelli G, Conte R, Cocco L, McCubrey JA, Martelli AM. Multidrug resistance-associated protein 1 expression is under the control of the phosphoinositide 3 kinase/Akt signal transduction network in human acute myelogenous leukemia blasts. Leukemia. 2007 Mar;21(3):427-38.

Gisselbrecht C, Bethge W, Duarte RF,Gianni AM, GlassB, Haioun C, Martinelli G, Nagler A,Pettengell R,Sureda A, Tilly H, Wilson K Current status and future perspectivesforyttrium-90 ((90)Y)-ibritumomab tiuxetan in stem cell transplantationfornon-Hodgkin’s lymphoma Bone Marrow Transplant. 2007 Dec;40(11):1007-17.

Zaja F, Bacigalupo A, Patriarca F, Stanzani M, Van Lint MT, Fili C, Scime R, Milone G, Falda M, Vener C, Laszlo D, Alessandrino PE, Narni F, Sica S, Olivieri A, Sperotto A, Bosi A, Bonifazi F, Fanin R; GITMO (Gruppo Italiano Trapianto Midollo Osseo). Treatment of refractory chronic GVHD with rituximab: a GITMO study. Bone Marrow Transplant. 2007 Aug;40(3):273-7.

Casarini L, Franchini A, Malagoli D,Ottaviani E Evaluation of the effects ofthe marine toxinokadaic acid by using FETAX assay Toxicol Lett, 2007 Mar 8;169(2):145-51.

Isidori A, Motta MR, Tani M, Terragna C, Zinzani PL, Curti A, Rizzi S, Giudice V, D’Addio A, Gugliotta G, Conte R, Baccarani M, Lemoli RM. Positive selection and transplantation of autologous highly purified CD133+ stem cells in resistant/relapsed chronic lymphocytic leukemia patients results in rapid hematopoietic reconstitution without an adequate leukemic cell purging. Biol Blood Marrow Transplant,2007 Oct;13(10):1224-32.

Soverini S, Martinelli G, Colarossi S, Gnani A, Rondoni M, Castagnetti F, Paolini S, Rosti G, Baccarani M. Second-line treatment with dasatinib in patients resistant to imatinib can select novel inhibitor-specific BCR-ABL mutants in Ph+ ALL. Lancet Oncol. 2007 Mar;8(3):273-4.

Cavo M. Nonmyeloablative allotransplantation for myeloma:light and shade. Blood. Apr 2007;109: 3134-3135.

Masetti M, Montalti R, Arpinati M, Di Benedetto F, Miller CM, Zagnoli A, De Ruvo N, Guerrini GP, Romano A, Rondelli D, Chirumbolo G, Rompianesi G, Pinna AD, Gerunda GE. High dose rabbit antithymocyte globulin induction in living related liver transplantation. Hepatogastroenterology. 2007 Apr-May;54(75):884-8.

Piccaluga PP, Agostinelli C, Righi S, Zinzani PL, Pileri SA. Expression of CD52 in peripheral T-cell lymphoma. Haematologica. 2007 Apr;92(4):566-7.

Morschhauser F, Zinzani PL, Burgess M, Sloots L, Bouafia F, Dumontet C. Phase I/II trial of a P-glycoprotein inhibitor, Zosuquidar.3HCl trihydrochloride (LY335979), given orally in combination with the CHOP regimen in patients with non-Hodgkin’s lymphoma. Leuk Lymphoma. 2007 Apr;48(4):708-15.

Soverini S, Iacobucci I, Baccarani M, Martinelli G. Targeted therapy and the T315I mutation in Philadelphia-positive leukemias. Haematologica. 2007 Apr;92(4):437-9.

Kantarjian HM, Cortes J, Guilhot F, Hochhaus A, Baccarani M, Lokey L. Diagnosis and management of chronic myeloid leukemia: a survey of American and European practice patterns. Cancer. 2007 Apr 1;109(7):1365-75.

Curti A, Pandolfi S, Valzasina B, Aluigi M, Isidori A, Ferri E, Salvestrini V, Bonanno G, Rutella S, Durelli I, Horenstein AL, Fiore F, Massaia M, Colombo MP, Baccarani M, Lemoli RM. Modulation of tryptophan catabolism by human leukemic cells results in the conversion of CD25- into CD25+ T regulatory cells. Blood. 2007 Apr 1;109(7):2871-7.

Cortes J, Rousselot P, Kim DW, Ritchie E, Hamerschlak N, Coutre S, Hochhaus A, Guilhot F, Saglio G, Apperley J, Ottmann O, Shah N, Erben P, Branford S, Agarwal P, Gollerkeri A, Baccarani M. Dasatinib induces complete hematologic and cytogenetic responses in patients with imatinib-resistant or -intolerant chronic myeloid leukemia in blast crisis. Blood. 2007 Apr 15;109(8):3207-13.

Piccaluga PP, Ascani S, Agostinelli C, Paolini S, Laterza C, Papayannidis C, Martinelli G, Visani G, Baccarani M, Pileri SA. Myeloid sarcoma of liver: an unusual cause of jaundice. Report of three cases and review of literature. Histopathology. 2007 May;50(6):802-5.

Vignetti M, Fazi P, Cimino G, Martinelli G, Di Raimondo F, Ferrara F, Meloni G, Ambrosetti A, Quarta G, Pagano L, Rege-Cambrin G, Elia L, Bertieri R, Annino L, Foa R, Baccarani M, Mandelli F. Imatinib plus steroids induces complete remissions and prolonged survival in elderly Philadelphia chromosome-positive patients with acute lymphoblastic leukemia without additional chemotherapy: results of the Gruppo Italiano Malattie Ematologiche dell’Adu Blood. 2007 May 1;109(9):3676-8.

Guilhot F, Apperley J, Kim DW, Bullorsky EO, Baccarani M, Roboz GJ, Amadori S, de Souza CA, Lipton JH, Hochhaus A, Heim D, Larson RA, Branford S, Muller MC, Agarwal P, Gollerkeri A, Talpaz M. Dasatinib induces significant hematologic and cytogenetic responses in patients with imatinib-resistant or -intolerant chronic myeloid leukemia in accelerated phase. Blood. 2007 May 15;109(10):4143-50.

Piccaluga PP, Finelli C, Vigna E, Agostinelli C, Bacci F, Paolini S, Papayannidis C, Laterza C, Martinelli G, Pileri SA, Baccarani M. Paraplegia due to a paravertebral extramedullary haemopoiesis in a patient with polycythaemia vera. J Clin Pathol. 2007 May;60(5):581-2.

Tazzari PL, Tabellini G, Bortul R, Papa V, Evangelisti C, Grafone T, Martinelli G, McCubrey JA, Martelli AM. The insulin-like growth factor-I receptor kinase inhibitor NVP-AEW541 induces apoptosis in acute myeloid leukemia cells exhibiting autocrine insulin-like growth factor-I secretion. Leukemia. 2007 May;21(5):886-96.

Cornely OA, Maertens J, Bresnik M,Ebrahimi R, UllmannAJ, Bouza E, Heussel CP, Lortholary O, Rieger C, Boehme A,Aoun M, Horst HA,Thiebaut A, Ruhnke M,Reichert D, Vianelli N, Krause SW,Olavarria E,Herbrecht R; AmBiLoad Trial Study Group Liposomal amphotericin B asinitial therapyfor invasive mold infection: a randomized trial comparing ahigh-loading doseregimen with standard dosing (AmBiLoad trial) Clin Infect Dis, 2007 May 15;44(10):1289-97.

Nanni C, Zamagni E, Cavo M, Rubello D, Tacchetti P, Pettinato C, Farsad M, Castellucci P, Ambrosini V, Montini GC, Al-Nahhas A, Franchi R, Fanti S. 11C-choline vs. 18F-FDG PET/CT in assessing bone involvement in patients with multiple myeloma. World J Surg Oncol. 2007 Jun 20;5:68.

Corradini P, Dodero A, Farina L, Fanin R, Patriarca F, Miceli R, Matteucci P, Bregni M, Scime R, Narni F, Pogliani E, Locasciulli A, Milani R, Carniti C, Bacigalupo A, Rambaldi A, Bonifazi F, Olivieri A, Gianni AM, Tarella C. Allogeneic stem cell transplantation following reduced-intensity conditioning can induce durable clinical and molecular remissions in relapsed lymphomas: pre-transplant disease status and histotype heavily influence outcome. Leukemia. 2007 Jun 28.

Jovanovic JV, Score J, Waghorn K, Cilloni D, Gottardi E, Metzgeroth G, Erben P, Popp H, Walz C, Hochhaus A, Roche-Lestienne C, Preudhomme C, Solomon E, Apperley J, Rondoni M, Ottaviani E, Martinelli G, Brito-Babapulle F, Saglio G, Hehlmann R, Cross NC, R Low-dose imatinib mesylate leads to rapid induction of major molecular responses and achievement of complete molecular remission in FIP1L1-PDGFRA-positive chronic eosinophilic leukemia. Blood. 2007 Jun 1;109(11):4635-40.

Malagoli D, Conklin D, Sacchi S,Mandrioli M, OttavianiE A putative helical cytokinefunctioning ininnate immune signalling in Drosophila melanogaster Biochim Biophys Acta. 2007Jun;1770(6):974-8.

Sabattini E, Orduz R, Campidelli C, Zinzani PL, Callea V, Zupo S, Cutrona G, Morabito F, Ferrarini M, Pileri S. B cell chronic lymphocytic leukaemia/small lymphocytic lymphoma: role of ZAP70 determination on bone marrow biopsy specimens. J Clin Pathol. 2007 Jun;60(6):627-32.

Cavo M, Tosi P, Zamagni E, Cellini C, Tacchetti P, Patriarca F, Di Raimondo F, Volpe E, Ronconi S, Cangini D, Narni F, Carubelli A, Masini L, Catalano L, Fiacchini M, de Vivo A, Gozzetti A, Lazzaro A, Tura S, Baccarani M. Prospective, randomized study of single compared with double autologous stem-cell transplantation for multiple myeloma: Bologna 96 clinical study. J Clin Oncol. 2007 Jun 10;25(17):2434-41.

Zinzani PL, Tani M, Trisolini R, Fanti S, Stefoni V, Alifano M, Castellucci P, Musuraca G, Dalpiaz G, Alinari L, Marchi E, Fina M, Pellegrini C, Farsad M, Cancellieri A, Busca A, Canini R, Pileri S, Baccarani M, Boaron M. Histological verification of positive positron emission tomography findings in the follow-up of patients with mediastinal lymphoma. Haematologica. 2007 Jun;92(6):771-7.

Hehlmann R, Hochhaus A, Baccarani M; European LeukemiaNet. Chronic myeloid leukaemia. Lancet. 2007 Jul 28;370(9584):342-50.

Cilloni D, Messa F, Martinelli G, Gottardi E, Arruga F, Defilippi I, Carturan S, Messa E, Fava M, Giugliano E, Rosso V, Catalano R, Merante S, Nicoli P, Rondoni M, Ottaviani E, Soverini S, Tiribelli M, Pane F, Baccarani M, Saglio G. WT1 transcript amount discriminates secondary or reactive eosinophilia from idiopathic hypereosinophilic syndrome or chronic eosinophilic leukemia. Leukemia. 2007 Jul;21(7):1442-50.

Mancini M, Brusa G, Zuffa E, Corrado P, Martinelli G, Grafone T, Barbieri E, Santucci MA. Persistent Cdk2 inactivation drives growth arrest of BCR-ABL-expressing cells in response to dual inhibitor of SRC and ABL kinases SKI606. Leuk Res. 2007 Jul;31(7):979-87.

Morschhauser F, Illidge T, Huglo D, Martinelli G, Paganelli G, Zinzani PL, Rule S, Liberati AM, Milpied N, Hess G, Stein H, Kalmus J, Marcus R. Efficacy and safety of yttrium-90 ibritumomab tiuxetan in patients with relapsed or refractory diffuse large B-cell lymphoma not appropriate for autologous stem-cell transplantation. Blood. 2007 Jul 1;110(1):54-8.

Plasmati R, Pastorelli F, Cavo M, Petracci E, Zamagni E, Tosi P, Cangini D, Tacchetti P, Salvi F, Bartolomei I, Michelucci R, Tassinari CA. Neuropathy in multiple myeloma treated with thalidomide: a prospective study. Neurology. 2007 Aug 7;69(6):573-81.

Palmisano M, Grafone T, Ottaviani E, Testoni N, Baccarani M, Martinelli G. NPM1 mutations are more stable than FLT3 mutations during the course of disease in patients with acute myeloid leukemia. Haematologica. 2007 Sep;92(9):1268-9.

Baccarani M, Cilloni D, Rondoni M, Ottaviani E, Messa F, Merante S, Tiribelli M, Buccisano F, Testoni N, Gottardi E, de Vivo A, Giugliano E, Iacobucci I, Paolini S, Soverini S, Rosti G, Rancati F, Astolfi C, Pane F, Saglio G, Martinelli G. The efficacy of imatinib mesylate in patients with FIP1L1-PDGFRalpha-positive hypereosinophilic syndrome. Results of a multicenter prospective study. Haematologica. 2007 Sep;92(9):1173-9.

Cilloni D, Martinelli G, Messa F, Baccarani M, Saglio G. Nuclear factor kB as a target for new drug development in myeloid malignancies. Haematologica. 2007 Sep;92(9):1224-9.

Zinzani PL, Musuraca G, Tani M, Stefoni V, Marchi E, Fina M, Pellegrini C, Alinari L, Derenzini E, de Vivo A, Sabattini E, Pileri S, Baccarani M. Phase II Trial of Proteasome Inhibitor Bortezomib in Patients With Relapsed or Refractory Cutaneous T-Cell Lymphoma. J Clin Oncol. 2007 Sep 20;25(27):4293-7.

Piccaluga PP, Paolini S, Martinelli G. Tyrosine kinase inhibitors for the treatment of Philadelphia chromosome-positive adult acute lymphoblastic leukemia. Cancer. 2007 Sep 15;110(6):1178-86.

Ottmann O, Dombret H, Martinelli G, Simonsson B, Guilhot F, Larson RA, Rege-Cambrin G, Radich J, Hochhaus A, Apanovitch AM, Gollerkeri A, Coutre S. Dasatinib induces rapid hematologic and cytogenetic responses in adult patients with Philadelphia chromosome-positive acute lymphoblastic leukemia with resistance or intolerance to imatinib: interim results of a Phase II study. Blood. 2007 Oct 1;110(7):2309-15.

Orciuolo E, Stanzani M, Canestraro M, Galimberti S, Carulli G, Lewis R, Petrini M, Komanduri KV. Effects of Aspergillus fumigatus gliotoxin and methylprednisolone on human neutrophils: implications for the pathogenesis of invasive aspergillosis. J Leukoc Biol. 2007 Oct;82(4):839-48.

Deininger MW, Cortes J, Paquette R, Park B, Hochhaus A, Baccarani M, Stone R, Fischer T, Kantarjian H, Niederwieser D, Gambacorti- Passerini C, So C, Gathmann I, Goldman JM, Smith D, Druker BJ, Guilhot F. The prognosis for patients with chronic myeloid leukemia who have clonal cytogenetic abnormalities in philadelphia chromosome- negative cells. Cancer. 2007 Oct 1;110(7):1509-19.

Piccaluga PP, Rondoni M, Paolini S, Rosti G, Martinelli G, Baccarani M. Imatinib mesylate in the treatment of hematologic malignancies. Expert Opin Biol Ther. 2007 Oct;7(10):1597-611.

Caraceni P, Giannone F, Catani L, Talarico S, Pertosa AM, Domenicali M, Fogli M, Principe A, Trevisani F, Baccarani M, Bernardi M, Lemoli RM. Effects of granulocyte colony stimulating-factor in a rat model of acute liver injury. Dig Liver Dis. 2007 Oct;39(10):943-951.

Palandri F, Iacobucci I, Quarantelli F, Castagnetti F, Cilloni D, Baccarani M; GIMEMA Working Party on CML. Long-term molecular responses to imatinib in patients with chronic myeloid leukemia: comparison between complete cytogenetic responders treated in early and in late chronic phase. Haematologica. 2007 Nov;92(11):1579-80.

Gahrton G, Iacobelli S,Bandini G, Björkstrand B,Corradini P, Crawley C,Hegenbart U, Morgan G, KrögerN, Schattenberg A,Schönland SO, Verdonck LF, Volin L, de Witte T,Niederwieser D; MyelomaSubcommittee of the EBMT Peripheral blood or bonemarrow cells inreduced-intensity or myeloablative conditioning allogeneic HLAidenticalsibling donor transplantation for multiple myeloma Haematologica, 2007 Nov;92(11):1513-8

Zinzani PL, Poletti V, Zompatori M, Tani M, Spaggiari L, Tomassetti S, Broccoli A, Derenzini E, Baccarani M. Bronchus-associated lymphoid tissue lymphomas: an update of a rare extranodal maltoma. Clin Lymphoma Myeloma. 2007 Nov;7(9):566-72.

Fina M, Tani M, Stefoni V, Musuraca G, Marchi E, Pellegrini C, Alinari L, Derenzini E, Bacci F, Pileri S, Baccarani M, Zinzani PL. VNCOP-B plus rituximab in the treatment of diffuse large B-cell lymphoma in the elderly. Leuk Lymphoma. 2007 Nov;48(11):2167-71.

Piccaluga PP, Agostinelli C, Califano A, Carbone A, Fantoni L, Ferrari S, Gazzola A, Gloghini A, Righi S, Rossi M, Tagliafico E, Zinzani PL, Zupo S, Baccarani M, Pileri SA. Gene expression analysis of angioimmunoblastic lymphoma indicates derivation from T follicular helper cells and vascular endothelial growth factor deregulation. Cancer Res. 2007 Nov 15;67(22):10703-10.

Giannecchini S, Campitelli L, BandiniG, Donatelli I,Azzi A Characterization of humanH1N1 influenza virusvariants selected in vitro with zanamivir in the presenceof sialicacid-containing molecules Virus Res. 2007 Nov;129(2):241-5.

Curti A, Tosi P, Comoli P, Terragna C, Ferri E, Cellini C, Massaia M, D’Addio A, Giudice V, Di Bello C, Cavo M, Conte R, Gugliotta G, Baccarani M, Lemoli RM. Phase I/II clinical trial of sequential subcutaneous and intravenous delivery of dendritic cell vaccination for refractory multiple myeloma using patient-specific tumour idiotype protein or idiotype (VDJ)-derived class I-restricted peptides. Br J Haematol. 2007 Nov;139(3):415-24.

Ferrucci PF, Vanazzi A, Grana CM,Cremonesi M,Bartolomei M, Chinol M, Ferrari M, Radice D, Papi S, MartinelliG, PaganelliG High activity90Y-ibritumomab tiuxetan(Zevalin) with peripheral blood progenitor cellssupport in patients withrefractory/resistant B-cell non- Hodgkin lymphomas Br J Haematol, 2007 Nov;139(4):590-9

Palumbo A, Rajkumar SV, Dimopoulos MA, RichardsonPG, San Miguel J, Barlogie B, Harousseau J, Zonder JA, Cavo M, Zangari M,Attal M, Belch A, Knop S, Joshua D, Ludwig H, Vesole D, Bladé J, Kyle R,Westin J, Weber D, Bringhen S, Niesvizky R, Waage A, von Lili Prevention of thalidomide- andlenalidomide-associated thrombosis in myeloma. Leukemia. 2007 Dec 20.

Brusa G, Zuffa E, Hattinger CM, SerraM, Remondini D,Castellani G, Righi S,Campidelli C, Pileri S, Zinzani PL,Gabriele A, ManciniM, Corrado P, Barbieri E,Santucci MA Genomic imbalancesassociated with secondaryacute leukemias in Hodgkin lymphoma Oncol Rep, 2007 Dec;18(6):1427-34.

ZamagniE, Valdrè L, Palareti G, Cavo M. Prevention of VTE in multiple myeloma patients. Thromb Res. 2007;120 Suppl 2:S133-6.

Ferrario M, Alesini D, Bacci A, Bellaveglia M, Boni R, Boscolo M, Castellano M, Catani L, Chiadroni E, Cialdi S, Cianchi A, Clozza A, Cultrera L, Di Pirro G, Drago A, Esposito A, Ficcadenti L, Filippetto D, Fusco V, Gallo A, Gatti G, Ghigo A, Giannessi L, Direct measurement of the double emittance minimum in the beam dynamics of the sparc high-brightness photoinjector. Phys Rev Lett. 2007 Dec 7;99(23):234801.

Piccaluga PP, Malagola M, Rondoni M, Arpinati M, Paolini S, Candoni A, Fanin R, Messa E, Pirrotta MT, Lauria F, Visani G, Alberti D, Rancati F, Vinaccia V, Russo D, Saglio G, Baccarani M, Martinelli G. Imatinib mesylate in the treatment of newly diagnosed or refractory/resistant c-KIT positive acute myeloid leukemia. Results of an Italian Multicentric Phase II Study. Haematologica. 2007 Dec;92(12):1721-2

Stanzani M, Tumietto F, Giannini MB, Bianchi G, Nanetti A, Vianelli N, Arpinati M, Giovannini M, Bonifazi F, Bandini G, Baccarani M. Successful treatment of multi-resistant Pseudomonas aeruginosa osteomyelitis after allogeneic bone marrow transplantation with a combination of colistin and tigecycline. J Med Microbiol. 2007 Dec;56(Pt 12):1692-5.

Pavletic SZ, Zhou G, Sobocinski K, Marti G, Doney K, Dipersio J, Feremans W, Foroni L, Goodman S, Prentice G, Lemaistre C, Bandini G, Ferrant A, Jacobsen N, Khouri I, Gale RP, Wiestner A, Giralt S, Montserrat E, Chan WC, Bredeson C. Genetically identical twin transplantation for chronic lymphocytic leukemia. Leukemia. 2007 Dec;21(12):2452-5.



 
Istituto di Ematologia "Lorenzo e Ariosto Seràgnoli" - Via Massarenti, 9 - 40138 Bologna - Tel. +39 051 636 3680 Fax +39 051 636 4037